Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Inari Medical Inc before investing.
In this article, we go over a few key elements for understanding Inari Medical Inc’s stock price such as:
- Inari Medical Inc’s current stock price and volume
- Why Inari Medical Inc’s stock price changed recently
- Upgrades and downgrades for NARI from analysts
- NARI’s stock price momentum as measured by its relative strength
About Inari Medical Inc (NARI)
Before we jump into Inari Medical Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.
Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.
Want to learn more about Inari Medical Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Inari Medical Inc.
Inari Medical Inc’s Stock Price as of Market Close
As of September 06, 2024, 4:00 PM, CST, Inari Medical Inc’s stock price was $45.52.
Inari Medical Inc is up 9.21% from its previous closing price of $41.68.
During the last market session, Inari Medical Inc’s stock traded between $40.70 and $43.39. Currently, there are 58.14 million shares of Inari Medical Inc stock available for purchase.
Unfortunately, Inari Medical Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.
Inari Medical Inc Stock Price History
Inari Medical Inc’s (NARI) price is currently up 5.3% so far this month.
During the month of September, Inari Medical Inc’s stock price has reached a high of $46.48 and a low of $40.70.
Over the last year, Inari Medical Inc has hit prices as high as $69.40 and as low as $36.73. Year to date, Inari Medical Inc’s stock is down 28.38%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused Inari Medical Inc Stock’s Price to Rise?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of September 05, 2024,, no analysts have changed their rating of Inari Medical Inc’s stock over the last month.
Additionally, you'll want to evaluate Inari Medical Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Inari Medical Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
Inari Medical Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Inari Medical Inc (NARI) by visiting AAII Stock Evaluator.
Relative Price Strength of Inari Medical Inc
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of September 05, 2024, Inari Medical Inc has a weighted four-quarter relative price strength of -13.44%, which translates to a Momentum Score of 26 and is considered to be Weak.
Want to learn more about how Inari Medical Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Inari Medical Inc Stock Price: Bottom Line
As of September 6, 2024, Inari Medical Inc’s stock price is $45.52, which is up 9.21% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Inari Medical Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
Yield Screen: 8.7% Compared to S&P 500
at only 6.9%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.